BKINTELLIFUSE Trademark

Trademark Overview

On Friday, February 2, 2024, a trademark application was filed for BKINTELLIFUSE with the United States Patent and Trademark Office. The USPTO has given the BKINTELLIFUSE trademark a serial number of 98388339. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, October 28, 2024. This trademark is owned by GE HealthCare Medical Technology LLC. The BKINTELLIFUSE trademark is filed in the Medical Instrument Products category with the following description:

A medical imaging system incorporating recorded AI technology-driven software, transducers, and tracking accessories for contouring the prostate and creating a pathway to identify abnormal tissue.
bkintellifuse

General Information

Serial Number98388339
Word MarkBKINTELLIFUSE
Filing DateFriday, February 2, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesA medical imaging system incorporating recorded AI technology-driven software, transducers, and tracking accessories for contouring the prostate and creating a pathway to identify abnormal tissue.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, March 1, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGE HealthCare Medical Technology LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWaukesha, WI 53188

Trademark Events

Event DateEvent Description
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Tuesday, April 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Tuesday, April 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 2, 2024NON-FINAL ACTION E-MAILED
Friday, June 7, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, June 7, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2024SUSPENSION LETTER WRITTEN
Monday, October 28, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 28, 2024LETTER OF SUSPENSION E-MAILED

Related Keywords

bkintellifuse prostate contouring accessories creating pathway tissue abnormal identify tracking transducers